Capital Advisory for Life Sciences
Our Promise
Who We Work With
Our Approach
Southern Cross Capital Advisors offers tailored funding solutions and expert guidance in the life sciences sector, focusing on operational realities like regulation, manufacturing, and technical transfer to ensure success.
Our Approach
Who We Work With
Our Approach
We partner in complex life science projects, providing strategic support that emphasizes regulatory compliance, manufacturing excellence, and technical transfer for superior outcomes.
Who We Work With
Who We Work With
Who We Work With
- Founders and executive leadership teams
- Owners of pharmaceutical and biotechnology enterprises
- Sponsors pursuing specialized credit opportunities
- Investors evaluating technically complex situations
- Companies with cGMP, regulatory, or manufacturing-driven capital needs
- Stakeholders seeking disciplined solutions in transitional or distressed settings
Expert Insights
Meet Our Expert
Dr. Sanjeev K. Gupta, Ph.D., R.Ph., is a leading Life Science Expert at Southern Cross Capital Advisors, bringing extensive experience in pharmaceutical R&D, quality systems, and manufacturing to support our clients' success.
Dr. Gupta is a senior pharmaceutical R&D, technical, quality, and regulatory executive with extensive experience across branded and generic drug development, manufacturing systems, quality compliance, commercialization, and regulatory execution. His profile reflects leadership in the development of 225+ new products, contributing to 170+ regulatory submissions and 105+ regulatory approvals and launches, including several first-to-file opportunities.
His experience spans:
- Pharmaceutical R&D leadership
- Quality and regulatory systems
- Manufacturing and process development
- Analytical and QC laboratory operations
- cGMP remediation and audit preparedness
- ANDA, NDA, BLA, and CMC support
- Technology transfer, validation, and commercialization strategy
Dr. Gupta is the founder of SanKav Pharmaceuticals LLC, a platform established to provide consulting and development services to pharmaceutical, biotechnology, and nutraceutical companies in the U.S. and abroad. His work includes biologics, cell and gene therapy, injectables, ophthalmics, topicals, controlled-release dosage forms, regulatory remediation, and commercial manufacturing support. The profile also notes SanKav’s development of analytical, microbiology, cell culture, research, and cGMP manufacturing capabilities in New Jersey.